Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer. [electronic resource]
Producer: 20131031Description: 1232-43 p. digitalISSN:- 1557-3265
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Cohort Studies
- Diphenylamine -- analogs & derivatives
- Female
- Follow-Up Studies
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Neoplasm Staging
- Neoplasms -- drug therapy
- Prognosis
- Protein Kinase Inhibitors -- pharmacokinetics
- Sulfonamides -- pharmacokinetics
- Tissue Distribution
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.